Literature DB >> 33872068

COVID-19: A Mitochondrial Perspective.

Pankaj Prasun1.   

Abstract

Coronavirus disease 2019 (COVID-19) is the worst public health crisis of the century. Although we have made tremendous progress in understanding the pathogenesis of this disease, a lot more remains to be learned. Mitochondria appear to be important in COVID-19 pathogenesis because of its role in innate antiviral immunity, as well as inflammation. This article examines pathogenesis of COVID-19 from a mitochondrial perspective and tries to answer some perplexing questions such as why the prognosis is so poor in those with obesity, metabolic syndrome, or type 2 diabetes. Although effective vaccines and antiviral drugs will be the ultimate solution to this crisis, a better understanding of disease mechanisms will open novel avenues for treatment and prevention.

Entities:  

Keywords:  COVID-19; SARS-CoV; coronavirus; interferon; mitochondria; oxidative stress

Year:  2021        PMID: 33872068     DOI: 10.1089/dna.2020.6453

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  10 in total

1.  Cytidine 5'-Diphosphocholine Corrects Alveolar Type II Cell Mitochondrial Dysfunction in Influenza-infected Mice.

Authors:  Lauren M Doolittle; Katherine Binzel; Katherine E Nolan; Kelsey Craig; Lucia E Rosas; Matthew C Bernier; Lisa M Joseph; Parker S Woods; Michael V Knopp; Ian C Davis
Journal:  Am J Respir Cell Mol Biol       Date:  2022-06       Impact factor: 7.748

Review 2.  Protons to Patients: targeting endosomal Na+ /H+ exchangers against COVID-19 and other viral diseases.

Authors:  Hari Prasad
Journal:  FEBS J       Date:  2021-09       Impact factor: 5.622

3.  Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study.

Authors:  Luke Bracegirdle; Alexander Jackson; Ryan Beecham; Maria Burova; Elsie Hunter; Laura G Hamilton; Darshni Pandya; Clare Morden; Michael P W Grocott; Andrew Cumpstey; Ahilanandan Dushianthan
Journal:  PLoS One       Date:  2022-06-10       Impact factor: 3.752

4.  Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?

Authors:  Emily M Hartsell; Mark N Gillespie; Raymond J Langley
Journal:  Eur Respir J       Date:  2022-02-24       Impact factor: 16.671

5.  Analysis of mitochondrial DNA cytochrome-b (CYB) and ATPase-6 gene mutations in COVID-19 patients.

Authors:  Ebubekir Dirican; Şeyda Tuba Savrun; İsmail Erkan Aydın; Gonca Gülbay; Ülkü Karaman
Journal:  J Med Virol       Date:  2022-03-22       Impact factor: 20.693

6.  Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS.

Authors:  Richa Batra; William Whalen; Sergio Alvarez-Mulett; Luis G Gómez-Escobar; Katherine L Hoffman; Will Simmons; John Harrington; Kelsey Chetnik; Mustafa Buyukozkan; Elisa Benedetti; Mary E Choi; Karsten Suhre; Edward Schenck; Augustine M K Choi; Frank Schmidt; Soo Jung Cho; Jan Krumsiek
Journal:  medRxiv       Date:  2022-08-13

7.  COVID-19 sequelae: can long-term effects be predicted?

Authors:  Eleni Gavriilaki; Styliani Kokoris
Journal:  Lancet Infect Dis       Date:  2022-08-25       Impact factor: 71.421

8.  Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS.

Authors:  Richa Batra; William Whalen; Sergio Alvarez-Mulett; Luis G Gomez-Escobar; Katherine L Hoffman; Will Simmons; John Harrington; Kelsey Chetnik; Mustafa Buyukozkan; Elisa Benedetti; Mary E Choi; Karsten Suhre; Edward Schenck; Augustine M K Choi; Frank Schmidt; Soo Jung Cho; Jan Krumsiek
Journal:  PLoS Pathog       Date:  2022-09-19       Impact factor: 7.464

9.  The biological activity of medical ozone in the hormetic range and the role of full expertise professionals.

Authors:  Marianno Franzini; Luigi Valdenassi; Sergio Pandolfi; Umberto Tirelli; Giovanni Ricevuti; Vincenzo Simonetti; Massimiliano Berretta; Francesco Vaiano; Salvatore Chirumbolo
Journal:  Front Public Health       Date:  2022-09-16

10.  Symptomatic SARS-CoV-2 Infection with Ageusia after Two mRNA Vaccine Doses.

Authors:  Vito Carlo Alberto Caponio; Maria Rosaria Lipsi; Francesca Fortunato; Fabio Arena; Lorenzo Lo Muzio
Journal:  Int J Environ Res Public Health       Date:  2022-01-13       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.